CD138+ Plasma Cell Enrichment directly from Bone Marrow
CD138 is vital for diagnosing plasma cell tumors and Multiple Myeloma. Traditional bone marrow analysis using the ficoll method is laborious and can lose key antigens like CD138. This app note showcases the MARS® platform’s efficiency in isolating CD138+ cells from raw bone marrow, enabling quicker and dependable CD138 expression analysis.
CD34+ cells are cruicial for understanding hematopoiesis, hematological conditions, and regenerative medicine. Their isolation from Cord Blood MNC is key for hematopoietic stem cell research and treatment breakthroughs. The MARS® Platform optimizes CD34+ cell enrichment, bolstering purity and viability, aiding in the evolution of personalized cellular therapies.
Liping leads application development, combining reagent, software, and MARS® platform to offer integrated solutions. She earned her PhD in Biophysics from Carnegie Mellon University and underwent postdoc training at Beckton Dickinson. With over a decade in the biotech sector, she’s directed innovative projects and handled partnerships. Her core expertise lies in cell analysis, separation, and analytical instruments.
Kat oversees global commercial operations, including marketing, product management, and partner collaborations. After earning her PhD in molecular microbiology in 2012, she pursued postdoctoral training at the University of Oxford and MBA studies at Boston University. She has experience in commercializing projects across startups in Poland, UK, and USA.
Chris is a dynamic, strategy-driven commercial leader with a solid footing in Clinical Diagnostics, Biotech, and Pharmaceuticals. He holds a BS in Biology from Rowan University and a certification in “Strategic Business Planning” from Wharton School of Business. A former Operations Specialist in the U.S. Navy, Chris has taken on leadership roles at Roche Diagnostics, Neta Scientific, and Miltenyi Biotech.
Our Global Distributor Team stands ready to facilitate your research journey, no matter where in the world you are. Committed to providing tailored solutions, support, and dedicated expertise, ensuring your research advances without boundaries. Reach out to us – we’re here for you, bridging geographical divides and pioneering research potentials together.
Achieve seamless cell isolation with unmatched purity using the MARS® MAG Premium Line. Developed in partnership with STEMCELL Technologies, these reagents facilitate quick and straightforward isolation of various cells, including CD138+ Plasma cells and CD34+ Stem Cells. With protocols tailored for MARS® instruments, the kits offer a comprehensive cell isolation solution for a rapid, automated, gentle, and proficient cell isolation.